Who should not take menopausal hormone therapy?

Key takeaways

• A small number of situations generally rule out systemic hormone therapy, such as a history of breast cancer, especially estrogen receptor positive disease.
• Many others are "caution" situations, where the type, route or dose is chosen carefully, or a specialist is involved.
• NICE says cardiovascular risk factors are not a contraindication if they are well managed, and that hormone therapy does not generally worsen blood sugar control in type 2 diabetes.
• Patches, gels and sprays are often considered for women at higher clot risk, including those with a BMI over 30.
• If hormone therapy is not right for you, effective non-hormonal options exist.

Why does "can I take it?" need a proper conversation?

Over the years I have met so many women who were told "you cannot take hormones" without any reason being explained. And I have met women who started tablets from a chemist on a friend's advice, with no assessment at all. Both are wrong, and both leave the woman worse off.

The decision depends on your full history: past illnesses, family history, blood pressure, weight, current medicines and what symptoms you are trying to treat. The route matters too. A skin patch behaves differently from a tablet in some situations, because a tablet goes through the liver first and a patch does not. So "who should not take it" is less a fixed list and more a set of questions your doctor should go through with you, one by one, like a pilot's checklist before take-off.

When is hormone therapy usually not advised?

These are situations where systemic hormone therapy (tablets, patches, gels, sprays) is generally avoided or needs to wait:

The University of Oxford's patient experience project on HRT lists a history of breast, ovarian or womb cancer, past blood clots, untreated high blood pressure, liver disease and pregnancy among situations where hormone therapy may not be suitable.

When is it possible, but with caution or specialist advice?

A past blood clot (DVT or pulmonary embolism) or a clotting disorder. NICE notes that oral estrogen raises clot risk above baseline, while transdermal estrogen at standard doses does not. For women at higher risk, NICE advises considering patches, gels or sprays, and haematology advice for those with a strong family history or an inherited clotting condition.

Stroke or heart attack in the past. These require careful specialist assessment. NICE notes that oral estrogen carries a small increase in stroke risk while transdermal does not.

A strong family history of breast cancer, or a known gene change. NICE advises that women at high risk should be offered all options and referred to a menopause specialist. Non-hormonal treatments are often first-line. See Does hormone therapy cause breast cancer?

Endometriosis or fibroids. These are not automatic barriers, but the choice of regimen matters, and fibroids should be assessed. MedlinePlus lists them among conditions to tell your doctor about before starting estrogen.

Migraine, epilepsy, gallbladder disease, high triglycerides. These are also on the list of conditions to discuss. They often influence the route or type rather than ruling treatment out.

Which conditions often do not rule it out?

This is the part many women find surprising. See, I'll tell you, half the "no" answers women have heard over the years fall into this list.

• Controlled high blood pressure. NICE says cardiovascular risk factors are not a contraindication to hormone therapy as long as they are optimally managed.
• Type 2 diabetes. NICE states that hormone therapy is not associated with an increased risk of developing type 2 diabetes and does not generally worsen blood sugar control. It can be considered for women with diabetes after looking at their other conditions.
• Age over 60. Starting is generally favoured before 60 or within 10 years of menopause, which is also the FDA's labelled recommendation since November 2025. But The Menopause Society says therapy does not need to be routinely stopped at 60 or 65 in women who are already on it and still benefiting.
• Being overweight. It is a reason to prefer a skin form and to work on weight, not usually a reason to refuse treatment.

What about women with a womb who want estrogen alone?

Estrogen without a progestogen is not advised for women who still have a womb. Estrogen alone makes the womb lining grow and raises the risk of endometrial cancer. The FDA has kept its boxed warning on this specific point, even as it began removing the broader warnings in November 2025. Women with a womb need a progestogen, by tablet, capsule, combined patch or a hormonal coil.

Before you start, what should be checked?

Hormone therapy does not need a huge battery of tests, but your doctor should cover: 1. Your symptoms and how they affect your life 2. Period pattern, and any abnormal bleeding 3. Personal and family history of breast, ovarian and womb cancer, clots, stroke and heart disease 4. Blood pressure, weight and waist 5. Breast awareness and screening appropriate to your age 6. Medicines you already take, including supplements and ayurvedic products 7. Only the blood tests or scans your history calls for

What if hormone therapy is not for you?

You are not left without options. The point is, symptoms still deserve treatment. CBT, clinical hypnosis, certain SSRI and SNRI medicines, gabapentin, oxybutynin and newer brain-targeted medicines all have evidence for hot flushes. For dryness, non-hormonal moisturisers and lubricants help, and vaginal estrogen may be possible for some women even when systemic therapy is not, after specialist discussion. See Non-hormonal treatments for hot flushes.

How I approach this at Dr Tvacha

At Cocoon × Dr Tvacha in Thane West, I go through your history in detail before hormone therapy is even discussed, and explain clearly whether it is suitable, suitable with a particular route, or better avoided. If specialist input is needed, for example from an oncologist or haematologist, I will tell you so. The Right Stop Programme is described on our women's health page; see also Menopausal hormone therapy explained.

Written by

Dr Anagha KarkhanisGynaecologist and Fertility Specialist · Reg. No. 2006/02/1187

Leads midlife women's health at Cocoon × Dr Tvacha, Thane.